[{"NetIncomeLoss_1_Q1_USD":-52546000.0,"ShareBasedCompensation_1_Q1_USD":6096000.0,"Assets_0_Q1_USD":309731000.0,"CommonStockSharesIssued_0_Q1_shares":16063199.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":478000.0,"AssetsCurrent_0_Q1_USD":308046000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-33464000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-14000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":44075000.0,"LiabilitiesNoncurrent_0_Q1_USD":387000.0,"InterestIncomeOther_1_Q1_USD":160000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":15840401.0,"GeneralAndAdministrativeExpense_1_Q1_USD":7209000.0,"PreferredStockSharesOutstanding_0_Q1_shares":1969797.0,"Liabilities_0_Q1_USD":49178000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":738575000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":387000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":44205000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-52607000.0,"StockIssuedDuringPeriodSharesNewIssues_1_Q1_shares":550803.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q1_USD":6096000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":67094000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":45770000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":113000.0,"Revenues_1_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":2000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-1147000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-61000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":707000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-191000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":978000.0,"PreferredStockSharesIssued_0_Q1_shares":1969797.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":4324000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":822000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":44205000.0,"AccountsPayableCurrent_0_Q1_USD":4396000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-9799000.0,"LiabilitiesCurrent_0_Q1_USD":48791000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-43429000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":93722000.0,"CommonStockSharesOutstanding_0_Q1_shares":16063199.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-478010000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":0.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":60302000.0,"OtherIncome_1_Q1_USD":273000.0,"StockholdersEquity_0_Q1_USD":260553000.0,"ProfitLoss_1_Q1_USD":-52546000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-3.32,"OperatingExpenses_1_Q1_USD":52979000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":320000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":6096000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":309731000.0,"PreferredStockValue_0_Q1_USD":null,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":263019000.0,"OperatingIncomeLoss_1_Q1_USD":-52979000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":3379000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":44000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1134000.0,"Ticker":"MDGL","CIK":"1157601","name":"MADRIGAL PHARMACEUTICALS, INC.","OfficialName":"Madrigal Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1322434501.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]